- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03344133
Effect of Exercise Programme on Gut Microbiota, CVD Risk Factors and Appetite Regulation in Overweight Women
Effect of a 4-week Moderate Intensity Exercise Programme on Gut Microbiota, Cardiovascular Disease Risk Factors and Appetite Regulation in Overweight Women
Přehled studie
Detailní popis
Study Design: This is a randomized controlled study with a parallel design. Healthy, sedentary females aged between 18-45 years old will be recruited by means of an advertisement leaflet and word of mouth. Eligible participants will be enrolled in the study and will be randomly allocated to either exercise intervention (EX) or control (C) groups. The EX group will participate in a 4-week exercise intervention and the C group will be asked to continue with habitual life style for 4 weeks. Before and after 4 weeks of the intervention, participants from both groups will be asked to conduct a submaximal exercise test and a 7-hour experimental trial during which blood samples will be collected and metabolic rate will measured before and after consumption of standardized breakfast and lunch. Prior to the first 7-hour trial, participants will be asked to record diet for 3 days and replicate this diet prior to the second 7-hour trial. During these 3 days participants will provide fresh stool samples. Participants allocated to control group will have the option to participate in exercise intervention. A subset of the participants will repeat a 7-hour experimental trial and provide fresh stool and urine sample after 7 days of detraining.
Methods:
Preliminary Health Check: Participants will undertake a health screening questionnaire on the day of recruitment. Participants will also need to fill in Physical Activity Readiness Questionnaire (PARQ). Only participants who answered "no" to all questions in PARQ will conduct the submaximal exercise test.
Anthropometry: All participants will have height, weight and waist circumference measured at baseline and 4 weeks after the intervention.
7-hour Experimental Trial: Participants will attend the metabolic suite (New Lister Building, Glasgow Royal infirmary) in a fasted state at approximately 9.00 am. Participants will be instructed to lie supine on the couch, with the head resting on the pillow provided. Resting metabolic rate will be measured for 20 minutes and fasting blood sample will be obtained. A breakfast meal will be consumed immediately after the fasting sample and a lunch meal after 4 hours. Blood samples will be taken throughout a cannula hourly after breakfast and lunch consumption. Following each blood sample, metabolic rate will be measured for the duration of 20 minutes. Prior each blood sample, participants will fill in appetite questionnaires. Blood samples will be analysed for plasma lipids, glucose, insulin, inflammatory markers and gut appetite hormones using standard existing procedures.
Feacal sample collection & analysis: A disposable stool sample collection kit will be provided prior to the 7-hour trial day. Once collected, the container is sealed and placed in a larger sealable bag with a reducing sachet to remove oxygen and maintain anaerobic bacteria. Stool samples will be measured for changes in gut microbiota based on 16S rRNA amplicon sequencing, bacterial functional capacity and targeted bacterial metabolites (short chain fatty acids, sulphide, ammonia).
Exercise Training Programme: Exercise training will consist of 4 weekly sessions of endurance type exercise (cycling and running) lasting for 30, 40, 50, 60 minutes in the week 1, 2, 3 and 4 respectively. The time and day of each training trial will be agreed between the investigator and the participant and will be based around the participant's availability. All exercise sessions will be supervised by a researcher.
Submaximal Exercise Test: Participants will exercise on treadmill at gradually increasing intensities until 85% of maximal heart rate. During the last minute of each of the intensities heart rate will be measured and expired air will be collected by Douglas bag technique and analysed for oxygen consumption and carbon dioxide production. Relation between heart rate and rate of oxygen consumption will be used to predict maximal oxygen consumption, a marker of cardio-respiratory fitness.
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Glasgow, Spojené království, G312ER
- Nábor
- School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary
-
Kontakt:
- Eleni Rizou, BSc MSc
- E-mail: e.rizou.1@research.gla.ac.uk
-
Kontakt:
- Konstantinos Gerasimidis, BSc MSc PhD
- E-mail: Konstantinos.Gerasimidis@glasgow.ac.uk
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Healthy, sedentary females, BMI>25 kg/m2, on a stable body weight for the last 3 months
Exclusion Criteria:
- Acute or chronic illness, use of antibiotics the past 3 months, smoking
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Exercise
4-week moderate intensity exercise programme
|
4-week moderate intensity exercise programme
|
|
Žádný zásah: Control
4 weeks of habitual life style
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Gut microbiota composition
Časové okno: 12 months
|
Changes in the gut microbiota composition measured by 16S rRNA amplicon sequencing.
|
12 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Interleukin-6 (IL-6)
Časové okno: 3 months
|
Changes in fasting and postprandial interleukin-6 pre- and post-interventions measured by Human IL-6 ELISA Ready-Set-Go (Affymetrix, eBioscience)
|
3 months
|
|
Glucose
Časové okno: 3 months
|
Changes in fasting glucose pre- and post-interventions measured by Randox Glucose
|
3 months
|
|
Triglycerides
Časové okno: 3 months
|
Changes in fasting and postprandial triglycerides pre- and post-interventions measured by Randox Triglycerides
|
3 months
|
|
Insulin
Časové okno: 3 months
|
Changes in fasting insulin pre- and post-interventions measured by Mercodia Insulin ELISA
|
3 months
|
|
Peptide YY (PYY)
Časové okno: 12 months
|
Changes in fasting and postprandial peptide YY pre- and post-interventions measured by Human PYY (Total) ELISA (Merc Millipore)
|
12 months
|
|
Glucagon-like peptide-1 (GLP-1)
Časové okno: 12 months
|
Changes in fasting and postprandial glucagon-like peptide-1 pre- and post-interventions measured by GLP-1 Total ELISA (Merc Millipore)
|
12 months
|
|
Subjective appetite
Časové okno: 12 months
|
Changes in subjective appetite (hunger, satiety, fullness, prospective food consumption, desire to eat) pre- and post-interventions measured by Visual Analogue Scales (VAS) where respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points (minimum score is 0 and maximum score is 100)
|
12 months
|
|
Faecal short-chain fatty acids
Časové okno: 12 months
|
Changes in concentrations of feacal short-chain fatty acids pre- and post-interventions measured by TRACE 2000 Gas Chromatography (ThermoQuest Ltd)
|
12 months
|
|
Faecal pH
Časové okno: 1 month
|
Changes in feacal pH between pre- and post-intervention measured by Hanna HI 98140
|
1 month
|
|
Body weight
Časové okno: 1 month
|
Differences in body weight (kilograms) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Height
Časové okno: 1 month
|
Height (meters) measured by stadiometer, a vertical ruler with a sliding horizontal paddle which is adjusted to rest on the top of the head
|
1 month
|
|
Body fat (kilograms)
Časové okno: 1 month
|
Differences in body fat expressed in kilograms between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Body fat (% percentage)
Časové okno: 1 month
|
Differences in body fat expressed as percentage (%) (proportion of fat to the total body weight) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Body Mass Index (BMI)
Časové okno: 1 month
|
Differences in body mass index (weight and height will be combined to report BMI in kg/m^2) between pre- and post-intervention measured by TANITA scales (TBF-300)
|
1 month
|
|
Dietary Intake
Časové okno: 6 months
|
Energy intake and macro nutrient intake using WinDiets software based on food composition tables
|
6 months
|
|
Maximum Oxygen Consumption
Časové okno: 2 weeks
|
Maximum Oxygen Consumption (ml/kg/min) measured before and after the interventions by Servomex Gas Analyser
|
2 weeks
|
|
Energy substrate oxidation
Časové okno: 6 months
|
Fat and carbohydrate oxidation in the fasted and postprandial state measured before and after the interventions using indirect calorimetry (Oxycon Pro)
|
6 months
|
|
Resting Metabolic Rate
Časové okno: 2 month
|
Resting metabolic rate was measured before and after the interventions (Oxycon Pro)
|
2 month
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Konstantinos Gerasimidis, BSc MSc PhD, University of Glasgow
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 200140132
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Nadváha a obezita
-
Cairo UniversityZatím nenabíráme
-
Cairo UniversityNeznámý
-
Cairo UniversityZatím nenabírámePit and fissur kaz | Zubní kaz; PočátečníEgypt
-
University of AarhusNáborFocused Acceptance and Commitment Therapy (FACT) | Čekací listinaDánsko
-
Nanfang Hospital, Southern Medical UniversityStomatological Hospital of Southern Medical University; Guanghua Stomatological...NáborInfekce kořenového kanálku | Post and Core Technika | Defekt zubuČína
-
The University of Hong KongDepartment of Health and Human ServicesNeznámýDítě | Pit and fissur kaz | Zub, mléčný | Skloionomerní cementyHongkong
-
Zhengzhou UniversityDokončenoEfektivita nákladů | Skloionomerní cement | Pit and fissur kaz (porucha)Čína
-
Thai Red Cross AIDS Research CentreMinistry of Health, ThailandDokončeno
-
Afyonkarahisar Health Sciences UniversityAktivní, ne náborPit and fissur kaz (porucha) | Těsnění důlků a trhlinTurecko (Türkiye)
-
Cairo UniversityDokončenoAmputace | Síla čtyřhlavého svalu | Transtibiální amputace – jednostranná | Timed Up and Go | Síla svalové sílyEgypt